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Q-T interval prolongation in cirrhosis: Relationship  
and severity 
 
Abstract 
Background: Cirrhosis as the final stage of progressive fibrosis of liver can affect other 
organs such as lungs, kidneys and heart. "Cirrhotic cardiomyopathy" involves the 
electrophysiological abnormalities such as QT interval prolongation. We assessed 
correlation between corrected QT interval prolongation and severity of cirrhosis based on 
Child Classification in each ECG lead. 
Methods: In this case-control study, the patients attending the outpatient clinic and 
inpatient department of internal medicine of Velayat Hospital in Qazvin were enrolled 
from September 2014 to July 2015. Total samples were 74 patients, half of which were 
used as controls. Cirrhosis severity was determined as per Child Classification. Both 
groups had Ca
2+
, Mg
2+
, K
+
 tested and 12- lead ECG was obtained. The QT interval was 
corrected by two different formulas: (1) QTc=QT/√RR (QTc1); (2) QTc=QT+1.75 (heart 
rate-60) (QTc2). To analyze the data, the software SPSS Version 16 and Mann-Whitney, 
Pearson’s chisquare test-Kruskal-Wallis, and t-tests were used. 
Results: The mean of QTc1 and QTc2 was longer in cirrhotics than the control group. 
There was a significant correlation between Child score and length of QTc1 in leads: III 
(p=0.032), AVL (p=0.041), V2 (p=0.049), V6 (p=0.015). There were significant 
differences in length of QTc1 in leads: V3 (p=0.031) and V6 (p=0.021); and QTc2 in lead 
V3 (p=0.039) between Child Classification. 
Conclusions: Cirrhosis can induce QTc interval prolongation. Lead V3 has statistically 
significant correlation with the severity of cirrhosis based on child classification. We 
propose that QT interval prolongation be added as a criterion for prioritizing liver 
transplantation. 
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Cirrhosis is the final stage of progressive fibrosis of liver which can also affect other 
organs such as the lungs, kidneys and heart simultaneously by poorly understood 
interactions. The term of "cirrhotic cardiomyopathy" was first used 20-30 years ago by 
'Lee' (1) to point out the cardiac dysfunction in cirrhosis. In 2005, a panel of expert 
hepatologists and cardiologists met at the World Congress of Gastroentrology and 
suggested to adopt the definition of cirrhotic cardiomyopathy as a form of chronic cardiac 
dysfunction in patients with cirrhosis. This would be characterized by reduced contractile 
responsiveness to stress, and/or altered diastolic relaxation and/or electrophysiological 
abnormalities in the absence of other known cardiac disease (2). Thus a part of this 
definition also involves the electrophysiological abnormalities, which can be seen on an 
electrocardiogram (ECG). One of these ECG findings are the prolongation of QT interval 
(1). Prolongation of the QT interval reflects prolongation of ventricular repolarization 
period that may result in fatal arrhythmias (3). 
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Large studies, like Cardiovascular Health Study, the 
NHAMES study, the Strong Heart Study, Rotterdom and a 
recent meta-analysis have shown a correlation between the 
prolongation of QTc and cardiovascular mortality rate and 
sudden death in general population as a whole (4), but the 
relation between the prolonged QTc and cardiovascular 
events need to be further studied in cirrhotic patients. We 
believe that cirrhosis can induce prolongation of QT interval 
and the length of QT interval directly correlates with the 
severity of cirrhosis that is indicated in the Child 
Classification and prolonged corrected QT interval can 
predict a higher risk in these patients. This additional risk of 
prolonged QT interval potentially can be added to the criteria 
for prioritization of hepatic transplantation. 
In the present study, we assessed the correlation between 
corrected QT interval prolongation and severity of cirrhosis 
based on Child Classification in each ECG lead. 
 
 
Methods 
In this case-control study, the patients attending the 
outpatient clinic and inpatient department of Internal 
Medicine of Velayat Hospital in Qazvin, were enrolled from 
September 2014 to July 2015.Total samples were 74 patients 
considered as the case (n=37) and control groups (n=37). In 
cirrhotic group (case), diagnosis was made on the basis of 
clinical, ultrasonography and histopathology and their 
severity was determined as per child scoring and 
classification system. Based on that, 12 patients were in class 
A, 12 in class B and 13 in class C. Also, on the same time 
frame, the control group was randomly selected from 
hospitalized patients at the same hospital, and did not have 
exclusion criteria. The control group was matched except for 
those with cirrhosis. In cirrhotics, serum albumin, prothrombin 
time, INR and total bilirubin were tested to determine their 
child score. Both groups had Ca
2+
, Mg
2+
, K
+ 
tested. 
Exclusion criteria from this study were: Serum calcium 
(Ca
+2
)<8.5 mg/dl (5) and/or serum potassium (K
+
) <3.6Mm 
(6) and/or serum magnesium (Mg
2)+
<1.8meq/dl (7), any 
bundle branch block in ECG, past history of ischemic or 
non-ischemic heart disease and drug history which could 
prolong the QT interval such as: macrolides and quinolones, 
tricyclics and selective serotonin reuptake inhibitors, 
haloperidol and phenotiazine, ondansetron and prochloperazine 
(8). After the selection of samples, 12- lead ECG was 
obtained from both groups (speed was set at 25mm/s and 
amplitude of 10mm/mV). QT interval was measured 
manually from the onset of Q wave(or R) to the end of T 
wave. End of T wave was taken to be where its descending 
limb returns to baseline. Thereafter, the QT interval was 
corrected by the following two different formulas; 
1. Bazett’s formula or formula#1 as QTc=QT/√RR. 
Corrected QT interval from this formula is called QTc1 in 
our report. 
2. Formula#2 as QTc=QT+1.75 (heart rate-60) (QT as per 
millisecond). Corrected QT interval from this formula is 
called QTc2 in our report. 
QTc longer than 0.45 second in females and 0.44 second 
in males were considered as prolonged by both formulas (4). 
To analyze the data, the following software and tests were 
used: the software SPSS16, Mann-Whitney test, t-test, 
Pearson-chi-square test and Kruskal-Wallis test. A p-value 
<0.05 was taken to be statistically significant. 
 
 
Results 
Data from 37 patients (21 males and 16 females) and 37 
controls (24 males and 13 females) were analyzed. Range of 
age in patients with cirrhosis was between 28 to 84 years old 
with the mean of 58.75±11.47 years. Range of age in the 
control group was from 30 to 82 with the mean of 
59.15±11.2 years. The two groups were matched according 
to age and gender (age: p=0.854, gender: p=0.475). The use 
of Mann-Whitney test showed that in all twelve leads, mean 
of QTc1 and QTc2 was longer in cirrhotic patients than that 
of the control group. The difference in these leads was 
statistically significant (table 1). By using the Pearson's 
correlation test, there was a statistically significant correlation 
between Child score and length of QTc1 in leads: III (R: 
0.354, p=0.032), AVL (R: 0.338, p=0.041), V2 (R: 0.326, 
p=0.049), V6 (R: 0.396, p=0.015). When we used Kruskal-
Wallis test, there were statistically significant differences 
between Child Classification and length of QTc1 in leads: V3 
(p=0.031) and V6 (p=0.021). Finally, by using Pearson  
[correlation between child score and length of QTc2 but by 
Kruskal-Wallis test, there was one shown in lead V3 (p=0.039). 
The number of patients with prolonged QTc1 was more in 
cirrhotic group as compared to the control group and this 
difference was statistically significant in all leads. But by 
using formula no.2, these differences were only statistically 
significant in leads: II, aVR, aVF, V3, V4, V5 and V6 (table 
2). 
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Table 1. Mean and SD of QTc1
§
 and QTc2
 §  
intervals per lead, in case (n=37) and control groups (n=37) 
 
Leads 
QTc1, 
mean±SD 
(per milisecond) 
 
QTc2,  
mean±SD 
(per milisecond) 
 
Case  
 
Control  
 
P-value* 
Case 
 
Control  
 
P-value* 
I 411 ± 39 391± 28 0.021 394 ± 34 377±23 0.016 
II 420±43 390±30 0.0014 403±38 377±26 0.002 
III 406±46 383±26 0.019 389±38 370±22 0.025 
aVR 426±47 395±25 0.002 410±37 380±22 0.000 
aVL 406±42 385±29 0.048 391±36 372±24 0.023 
aVF 420±39 384±30 0.000 401±33 372±26 0.000 
V1 410±34 381±34 0.001 394±27 368±28 0.001 
V2 421±41 390±28 0.000 403±34 377±23 0.000 
V3 427±43 400±29 0.002 407±35 385±24 0.003 
V4 431±39 398±28 0.000 412±33 385±24 0.001 
V5 423±45 397±28 0.005 408±38 384±26 0.002 
V6 421±40 392±29 0.001 405±34 379±26 0.001 
*P-value<0.05 is statisticallay significant. 
§QTc1 is corrected QT interval that calculated by formula No.1as:QT/√RR.  QTc2 is corrected QT interval that calculated by formula No.2 as: QT 
(per millisecond)+1.75(Heart rate-60) . 
 
Table 2. Prolonged
§
 QTc1
¶
 and QTc2 interval per lead in case (n=37) and control group (n=37) 
 
Leads Length of QT 
QTc1, 
mean±SD 
(per milisecond) 
 
QTc2,  
mean±SD 
(per milisecond) 
 
Case  
 
Control  
 
P-value* 
Case 
 
Control  
 
P-value* 
I Normal  30 (81.1%) 37 (100%) 0.005 36 (97.3%) 37 (100%) 0.314 
II Prolonged 7 (18.9%) -  1 (2.7%) -  
III Normal  25(67.6%) 37(100%) 0.000 33(89%) 37(100%) 0.040 
aVR Prolonged 12(32.47) -  4(11%) -  
aVL Normal  28(75.7%) 37(100%) 0.001 34(91%) 37(100%) 0.077 
aVF Prolonged 9(24.3%) -  3(9%) -  
V1 Normal  25(67.6%) 36(97.3) 0.001 32(86%) 37(100%) 0.021 
V2 Prolonged 12(92.3%) 1(2.7%)  5(14%) -  
V3 Normal  29(78.4%) 37(100%) 0.003 36(97%) 37(100%) 0.314 
V4 Prolonged 8(21.6%) -  1(3%) -  
V5 Normal  29(78.4%) 37(100%) 0.003 33(89%) 37(100%) 0.040 
V6 Prolonged 8(21.6%) -  4(11%) -  
*P-value<0.05 is statistically significant.                                                                                                         
¶ QTc1 is corrected QT interval that calculated by formula No: 1as: QT/√RR . QTc2 is corrected QT interval that calculated by formula No:2 as: 
QTc2=QT(per millisecond)+1.75(Heart rate-60)                                                                    
§ QTc1 and QTc2 higher than 0.450 second for females and higher than 0.440 second in males were considered prolonged.  
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Discussion  
In the present study, we assessed correlation between 
corrected QT interval prolongation and severity of cirrhosis 
based on Child Classification in each ECG lead. Results 
showed that mean of QTc1 and QTc2 were longer in 
cirrhotics than control group. There was a significant 
correlation between Child score and length of QTc1 in leads: 
III, AVL, V2, V6. Besides, there were significant differences 
in length of QTc1 in leads: V3 and V6; and QTc2 in lead V3 
between Child Classification. 
In a study done in 2003 by Midis et al., 52 cirrhotic 
patients were entered into a study where the severity of 
cirrhosis was scored by Child-Pugh classification (9). In that 
study, QTc was longer in cirrhotic group as compared to the 
control group (0.471 second, P=0.0007 and 0.461 second, 
P=0.0017) and prolongation of QTc in cirrhotic patients had 
a correlation with the Child B and C classification which was 
statistically significant (0.489 second, p=0.001 and 0.480 
second, p=0.0002) but not so in child A classification in 
cirrhotics (0.445 second, p=0.4366). In another study done 
by Patel D et al. in 2014, a number of 51 cirrhotic patients 
were without heart disease. In this study, prolonged QT was 
associated with worse liver function (higher INR, lower 
albumin) (10).  
In the study done in Romania in 2011 (11), there was a 
statistically significant correlation with the QTc and Child 
Classification. QTc was significantly longer in class C 
patients (520±45 milliseconds) compared with those in class 
"A" in cirrhotics (462±25 milliseconds; p=0.027). In study 
by Marafioti V et al. in 2015, QT interval prolongation was 
strongly associated with hepathic encephalopathy (12).  In 
previous studies done on the correlation between QT interval 
prolongation and cirrhosis, only Bazett's formula was used. 
This formula has a low accuracy.More than 30% of normal 
ECGs have been reported as having prolonged QT with this 
formula.This is because it overcorrects the QT interval in 
low heart rate and undercorrects it in higher heart rates (13).
 
In our study, we corrected QT interval with 2 formulas; first, 
the Bazette formula as: QTc=QT/√RR and second formula 
as: QTc=QT+1.75 (heart rate-60) (per millisecond). The 
latter formula is the newest formula recommended by Joint 
Committee of Professional Organization. This formula is a 
linear formula which is less affected by patient's heart rate
 
(13).
 
 Therefore, in our opinion, the results of present study 
are more accurate than previous studies about corrected QT 
interval prolongation and cirrhosis.
 
The current study showed that not only cirrhosis can 
induce QT interval prolongation but also in lead V3, the 
prolongation of QT interval directly correlates with the 
severity of cirrhosis based on Child classification using both 
formulas (QTc1: P=0.031, QTc2: P=0.039). 
Unlike in general population and patients with ischemic 
heart disease, the pathophysiology and complication of 
prolonged QT in cirrhotic patients is poorly understood. It 
may turn out that, cirrhotics may be more resistant to 
complication of QT interval prolongation by unknown 
mechanism in comparison with general population and 
patients with ischemic heart disease, although in  a study by 
Kim SM et al. in 2017, QT interval prolongation in cirrhotic 
patients increased the risk of mortality (14). 
Until further studies are done, there should be efforts to 
avoid factors which would contribute to this prolongation. 
For example, fluoroquinolones are used widely for urinary 
tract infection (UTI) and prophylaxis of spontaneous 
bacterial peritonitis (SBP) in cirrhotics can induce QT 
interval prolongation; therefore, these medications should be 
used with caution if absolutely indicated. Likewise, 
electrolyte imbalance like hypokalemia, hypocalcemia and 
hypomagnesemia which could result to diuretics and 
malnutrition should be vigorously corrected. We believe that 
more attention should be given to QT interval prolongation 
at pre, pri, and postoperative care of cirrhotics undergoing 
liver transplantation. Hence during cardiovascular 
assessment, to determine the cardiac risk of liver 
transplantation, physicians should pay more attention to QT 
interval prolongation at pre-,peri- and postoperative care of 
cirrhotic patients. 
This study has several limitations. First, it was basically a 
cross-sectional study, and unfortunately, we did not access to 
ECG before cirrhosis and after liver transplantation. As a 
result, we could not evaluate the degree of QT lengthening in 
correlation with cirrhosis and liver transplantation. Second, 
besides the severity of cirrhosis, the etiology of cirrhosis 
may influence the length of QT interval. This however was 
not evaluated in our study. In total, cirrhosis can induce QTc 
interval prolongation. In Patel D et al.’s study in 2014, 
besides the other known factors affecting repolarization, 
cirrhosis can affect ventricular repolarization and induced 
longed QT (10). In another study by Young Huh et al. in 
2014, QT interval in child class C patients was longer than 
child class A patients (15). Lead V3 has statistically 
significant correlation with the severity of cirrhosis based on 
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child classification in both formulas used. (QTc1: p=0.031, 
QTc2: p=0.039). Perhaps, QT interval prolongation can be a 
prognostic factor in more advanced cirrhosis with higher 
risk. As a consequence, we propose that QT interval 
prolongation be added as a criterion for prioritizing liver 
transplantation. 
In conclusion, cirrhosis can induce QTc interval 
prolongation. Lead V3 has statistically significant correlation 
with the severity of cirrhosis based on Child Classification.  
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